OpenAI has introduced Rosalind Biodefense, a new program designed to strengthen societal resilience against biological threats through advanced AI. The initiative provides trusted developers, public health organizations, and select government partners with access to GPT-Rosalind, OpenAI’s life sciences reasoning model.
OpenAI says the program will support applications in epidemiological modeling, early detection, outbreak response planning, diagnostics, vaccine research, and medical countermeasure development. Initial partners include Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory, and the Coalition for Epidemic Preparedness Innovations (CEPI).
The company describes Rosalind Biodefense as part of a broader strategy to ensure frontier AI benefits defenders working to prevent, detect, and respond to future biological threats and pandemics.
